Leukemia Clinical Trials

Showing 6201-6220 of 10,987 trials

Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

NCT04215627

The aim of this study is to compare hemodynamic monitoring using the invasive PiCCO device to the BB-613PW wireless, non-invasive PPG-based device, in critically ill patients within the ICU, suffering from hemodynamic instability and in need of vasopressor support. Data will be gathered prospectively and analysed retrospectively.

Critically IllHemodynamic Instability

Biobeat Technologies Ltd.9 participantsStarted Dec 2019

Rishon LeZiyyon, Israel

TERMINATEDPhase 1/2

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

NCT02440568

This is a dose escalation study to evaluate Omacetaxine when given in combination with a standard induction regimen of "7+3" (cytarabine for Days 1-7 and Idarubicin for Days 1-3) in patients with newly diagnosed acute myelogenous leukemia (AML).

Acute Myeloid Leukemia

University of Illinois at Chicago22 participantsStarted Jun 2015

Chicago, Illinois, United States

UNKNOWNNA

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

NCT04950400

The purpose of the study is to evaluate the safety and efficacy of camrelizumab combined with chemotherapy in the first-line treatment of advanced in NSCLC patients.

Non-small Cell Lung Cancer

Beijing Chest Hospital60 participantsStarted Jul 2021

Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Related Searches

Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

A Study of AK-01 (LY3295668) in Solid Tumors

The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line

The Correlation Between Fasicitis Plantaris and Hallux Rigidus

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Frailty and Falls Implantable System for Prediction and Prevention

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Tumor Mutational Burden in Lung Cancer Patients